The daily business briefing: March 31, 2020

Johnson & Johnson starts testing of coronavirus vaccine, GE workers call for making ventilators in idled plants, and more

The Johnson & Johnson sign
(Image credit: Mario Tama/Getty Images)

1. Johnson & Johnson starts testing of coronavirus vaccine

Johnson & Johnson said Monday it would start human testing of its experimental coronavirus vaccine in September. The company said it would invest more than $1 billion to co-fund the research with the federal Biomedical Advanced Research and Development Authority, part of the Department of Health and Human Services. Clinical data from the testing is expected by the end of the year. If all goes well, the vaccine could be available to be authorized for emergency use early next year. "The world is facing an urgent public health crisis and we are committed to doing our part to make a COVID-19 vaccine available and affordable globally as quickly as possible,” chairman and CEO Alex Gorsky said.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
Explore More
Harold Maass, The Week US

Harold Maass is a contributing editor at The Week. He has been writing for The Week since the 2001 debut of the U.S. print edition and served as editor of TheWeek.com when it launched in 2008. Harold started his career as a newspaper reporter in South Florida and Haiti. He has previously worked for a variety of news outlets, including The Miami Herald, ABC News and Fox News, and for several years wrote a daily roundup of financial news for The Week and Yahoo Finance.